title: Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma.
authors.affiliation: Oncology and Immunology Unit, Room 443, David Maddison Clinical Sciences Building, King & Watt Streets, Newcastle, NSW, 2300, Australia. Peter.Hersey@newcastle.edu.au
authors.forename: Peter
authors.initials: P
authors.lastname: Hersey
authors.forename: Scott W
authors.initials: SW
authors.lastname: Menzies
authors.forename: Brendon
authors.initials: B
authors.lastname: Coventry
authors.forename: Tam
authors.initials: T
authors.lastname: Nguyen
authors.forename: Margaret
authors.initials: M
authors.lastname: Farrelly
authors.forename: Susan
authors.initials: S
authors.lastname: Collins
authors.forename: Debbie
authors.initials: D
authors.lastname: Hirst
authors.forename: Heather
authors.initials: H
authors.lastname: Johnson
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000737:chemistry; D016207:Cytokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000737:chemistry; D018984:Epitopes, T-Lymphocyte / Q000737:chemistry*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007167:Immunotherapy / Q000379:methods*; D007249:Inflammation; D007371:Interferon-gamma / Q000378:metabolism; D008214:Lymphocytes / Q000276:immunology; D058965:MART-1 Antigen; D008297:Male; D008353:Mannitol / Q000031:analogs & derivatives* / Q000494:pharmacology; D008545:Melanoma / Q000276:immunology* / Q000628:therapy; D008562:Membrane Glycoproteins / Q000737:chemistry; D008875:Middle Aged; D014442:Monophenol Monooxygenase / Q000737:chemistry; D009363:Neoplasm Proteins / Q000737:chemistry; D009829:Oleic Acids / Q000494:pharmacology; D010455:Peptides / Q000737:chemistry; D012878:Skin Neoplasms / Q000276:immunology* / Q000628:therapy; D013997:Time Factors; D016896:Treatment Outcome; D058951:gp100 Melanoma Antigen
chemical_list: D000951:Antigens, Neoplasm; D016207:Cytokines; D000939:Epitopes; D018984:Epitopes, T-Lymphocyte; C072013:MAGEA3 protein, human; D058965:MART-1 Antigen; C548667:MLANA protein, human; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D009829:Oleic Acids; C548637:PMEL protein, human; D010455:Peptides; D058951:gp100 Melanoma Antigen; C001681:mannide monooleate; D008353:Mannitol; D007371:Interferon-gamma; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D014442:Monophenol Monooxygenase